- Home
- ACHV vs CFBK Comparison
ACHV vs CFBK Comparison
Compare ACHV & CFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACHV | CFBK |
|---|---|---|
| Founded | N/A | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 154.4M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ACHV | CFBK |
|---|---|---|
| Price | $4.88 | $23.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.50 | ★ $29.00 |
| AVG Volume (30 Days) | ★ 686.8K | 23.6K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 1.33% |
| EPS Growth | N/A | ★ 21.79 |
| EPS | N/A | ★ 2.49 |
| Revenue | N/A | ★ $50,724,000.00 |
| Revenue This Year | N/A | $39.98 |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $1.84 | $19.23 |
| 52 Week High | $5.78 | $29.51 |
Technical Indicators
Market Signals| Indicator | ACHV | CFBK |
|---|---|---|
| Relative Strength Index (RSI) | 60.25 | 60.76 |
| Support Level | $3.82 | $22.59 |
| Resistance Level | $4.99 | $24.22 |
| Average True Range (ATR) | 0.32 | 0.41 |
| MACD | -0.01 | 0.16 |
| Stochastic Oscillator | 90.17 | 87.26 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About CFBK CF Bankshares Inc.
CF Bankshares Inc is engaged in the provision of a variety of financial services. It provides personalized business banking products and services, including commercial loans and leases, commercial and residential real estate loans, equipment leasing, SBA loans and treasury management depository services. The revenues are derived principally from the interest and fees on loans originated and noninterest income generated on the sale of loans.